Posted on December 10, 202012/10/20
EVERSANA Receives PM360 Innovations Award for Seamlessly Disrupting Commercialization
Posted on December 4, 202012/4/20
A New Pharmaceutical Strategy for Europe
Posted on December 3, 202012/3/20
What Happens After a COVID-19 Vaccine Trial Succeeds? 4 Pharmacovigilance Challenges to Address During Commercialization
Posted on December 2, 202012/2/20
Solving Hard Go-To-Market Challenges [Webinar]
Posted on November 30, 202011/30/20
Case Study: Early-Stage Asset Valuation
Posted on November 6, 202011/6/20
The Power of Working Together With the Rare Disease Community
Posted on October 22, 202010/22/20
Unlock Europe To Create Value
Posted on October 21, 202010/21/20
MARKET ACCESS AND TREATMENT OUTCOMES: Shifting From the Volume of Data to the Value of Insights
Posted on October 15, 202010/15/20
Mitigating Risk: When A Curveball Threatens Your Product’s Launch
Posted on October 13, 202010/13/20